Cite
MLA Citation
H.W. Tessen et al.. “3106 Open label, multicenter, prospective non-interventional study to monitor the safety and effectiveness of Bevacizumab with chemotherapy in patients with NSCLC under conditions of routine clinical practice in Germany.” European journal of cancer, vol. 51, n.d., pp. S637–. http://access.bl.uk/ark:/81055/vdc_100030628321.0x00005c